| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net cash flows used in financing activities | -1,063 | -61 |
| Effect of exchange rate changes on cash | 16 | 15 |
| Net decrease in cash and cash equivalents | -1,096 | -504 |
| Cash and cash equivalents at beginning of period | 1,389 | - |
| Cash and cash equivalents at end of period | 293 | - |
Emmaus Life Sciences, Inc. (EMMA)
Emmaus Life Sciences, Inc. (EMMA)